Author(s):
M. Sai Nikitha, M. Veena, M. Sneha, M. Sai Sreeya, M. Durga Prerana, D. Sunitha, M. Sudhakar
Email(s):
basasunitha@gmail.com
DOI:
10.52711/2231-5713.2025.00047 
Address:
M. Sai Nikitha, M. Veena, M. Sneha, M. Sai Sreeya, M. Durga Prerana, D. Sunitha1*, M. Sudhakar2
1Department of Pharmaceutical Chemistry, Malla Reddy College of Pharmacy, Maisammaguda, Secunderabad, Osmania University, Telangana, India.
2Department of Pharmaceutics, Malla Reddy College of Pharmacy, Maisammaguda, Secunderabad, Osmania University, Telangana, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 3,
Year - 2025
ABSTRACT:
Transdermal drug delivery system has emerged apromising alternative to traditional oral and injectable methods for delivering therapeutics through the skin. This system facilitates controlled release of drugs over extended periods. Today about 74% of drugs are taken orally and are found not to be as effectual as long. To improve such character’s transdermal drug delivery system was become apparent. Advances in TDDS have been significantly made by developments in permeation enhancers, novel drug formulation and the use of micro needles nanoparticles to increase penetration. The gloopy of the TDDS is critical to the safety, efficacy and quality of a drug. In this review, we describe the different types of available TDDS methods, along with a critical discussion of the specific advantages and disadvantages, characterization methods, and potential of each method1.
Cite this article:
M. Sai Nikitha, M. Veena, M. Sneha, M. Sai Sreeya, M. Durga Prerana, D. Sunitha, M. Sudhakar. Advancements in Transdermal Drug Delivery System. Asian Journal of Pharmacy and Technology. 2025; 15(3):312-0. doi: 10.52711/2231-5713.2025.00047
Cite(Electronic):
M. Sai Nikitha, M. Veena, M. Sneha, M. Sai Sreeya, M. Durga Prerana, D. Sunitha, M. Sudhakar. Advancements in Transdermal Drug Delivery System. Asian Journal of Pharmacy and Technology. 2025; 15(3):312-0. doi: 10.52711/2231-5713.2025.00047 Available on: https://ajptonline.com/AbstractView.aspx?PID=2025-15-3-15
REFERENCES:
1. Jain. Controlled and Novel Drug Delivery. CBS Publishers, and Distributors, 2002; 107.
2. Chowdary K.P.R and Naidu RAS. Transdermal Drug Delivery. A Review of Current Status, Indian Drugs, 1995; 32(9):414-422.
3. Hadgraft J Guy R.H. Transdermal Drug Delivery, New York: Marcel Dekker, 2nd Ed; 35:14-16.
4. Hadgraft JW, and Somers G.F. Review Article Percutaneous absorption, International Journal of Pharmaceutics. 2005; 305:2-12
5. AC Williams, BW Barry. Penetration enchancers. Adv Drug Delivery Rev. 2012; 64(5): 128-137.
6. G.K Menon New Insights into skin structure: scratching the surface Adv Drug Delivery Rev. 2002; 5(4): 13-17.
7. HA Benson AC Watkinson Topical and Transdermal Drug Delivery: principles and practice Wiley Hoboken, NJ, USA.2012.
8. Heather AE. Transdermal drug delivery: penetration Enhancement Techniques. Current Drug Delivery. 2005; (2): 23-33.
9. Singh MC, Naik AS, Sawant SD, Transdermal drug delivery system with major emphasis on transdermal patches: a review. J Pharm Res. 2010; 3(10):2537-2543.
10. M Imani F Lahooti- Fard SM Taghizadeh M Tarkrousta Effect of adhesive layer thickness and drug delivery system. AAPS Pharm Sci. 2011; 326-334.
11. P Kumar C Sankar B Mishra Delivery of macromolecules through skin Indian Pharm. 2004; 5(3): 717.
12. OA AI Hanbali HMS Khan M Sarfar M Arafat Ijaz Hameed Transdermal patches: Design and current approaches to painless drug delivery Acta Pharm. 2019; 69219715
13. S Dhiman TG Singh AK Rehni Transdermal patches; a recent approach to new drug delivery system J Pharm Sci 2011;326-334
14. S Rani K Saroha N Syan P Mathur Transdermal patches a successful tool in transdermal drug delivery system; an overview. Der Pharm SINICA. 2011; 2: 17-29.
15. A Arunachalam M Karthikeyan D V Kumar M Prathap S Sethuram A S Kumar Tansdermal drug delivery system: A review. Current Pharma Res. 2010; 1(4):70-81.
16. CL Stevenson JT Satini R Langer Reserviour-based drug delivery system utilizing microtechnology. Adv Drug Delivery Rev. 2012; 6(4): 590-602.
17. Koteshwar K.B, Udupa N and Vasanthab Kumar, Desgin and Evaluation of Captopril Transdermal Preparations, Indian Drugs. 2020; 15(29): 680-685.
18. Priyanka Arora, Biswajit Mukherjee. Design Development Physiochemical and in-vitro. Evaluation of Tansdermal Patches Containing Diclopenac Diethylammonium Salt, Journal of Pharmaceutical Sciences. 2002: 91(9): 2076-2089.
19. Sankar V, VelrajanG, Palanippan R and Rajasekar S, Desgin and Evaluation OF Nifedipine Transdermal Patches, Indian Journal of Pharmaceutical Sciences. 2003; 65(5): 510-515.
20. Manvi F, V, Dandagi P.M, Gadad A.P, Mastiholimat VS and Jagdeesh T. Formulation of Transdermal Drug Delivery System of Ketotifen Furamate, Indian Journal of Pharmaecutical Sciences. 2013; 65(3): 239-24.
21. Invernale MA, Tang BC, York RL, Le L, Hou DY, Anderson DG. Microneedle electrodes toward an amperometric glucose-sensing smart patch. Adv. Health Matter. 2014; 3: 338–342.
22. Veiseh O, Langer R. Diabetes: A smart insulin patch. Nature. 2015; 524: 39–40.
23. Yu J., Zhang Y., Ye Y., DiSanto R., Sun W., Ranson D., Ligler F.S., Buse J.B., Gu Z. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc. Natl. Acad. Sci. USA. 2015; 112:8260–8265.
24. Iversen M., Monisha M., Agarwala S. Flexible, Wearable and Fully-printed Smart Patch for pH and Hydration Sensing in Wounds. Int. J. Bioprinting. 2022; 8:447.
25. Liu H., Li Z., Che S., Feng Y., Guan L., Yang X., Zhao Y., Wang J, Zvyagin A.V., Yang B., et al. A smart hydrogel patch with high transparency, adhesiveness and hemostasis for all-round treatment and glucose monitoring of diabetic foot ulcers. J. Mater. Chem. B. 2022; 10:5804–5817.
26. Gilpin V., Surandhiran D., Scott C., Devine A., Cundell J.H., Gill C.I.R., Pourshahidi L.K., Davis J. Lasered Graphene Microheaters Modified with Phase-Change Composites: New Approach to Smart Patch Drug Delivery. Micromachines. 2022; 13:1132.
27. Rodgers A.M., McCrudden M.T.C., Courtenay A.J., Kearney M.C., Edwards K.L., Ingram R.J., Bengoechea J., Donnelly R.F. Control of Klebsiella pneumoniae Infection in Mice by Using Dissolving Microarray Patches Containing Gentamicin. Antimicrobial. Agents Chemother. 2019; 63:12-18.
28. Lee IC, Lin W.M., Shu J.C., Tsai S.W., Chen C.H., Tsai M.T. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice. J. Biomed. Mater. Res. Part A. 2017; 105:84–93. Doi: 10.1002/jbm.a.35869.
29. Kim H., Seong K.Y., Lee J.H., Park W., Yang S.Y., Hahn S.K. Biodegradable Microneedle Patch Delivering Antigenic Peptide-Hyaluronate Conjugate for Cancer Immunotherapy. ACS Biomater. Sci. Eng. 2019; 5:5150–5158.
30. Li Y., Liu F., Su C., Yu B., Liu D., Chen H.J., Lin D.A., Yang C., Zhou L., Wu Q., et al. Biodegradable Therapeutic Microneedle Patch for Rapid Antihypertensive Treatment. ACS Appl. Mater. Interfaces. 2019; 11:30575–30584.
31. Zhang S., Liu C., Song Y., Ruan J., Quan P., Fang L. High drug-loading and controlled-release hydroxyphenyl-polyacrylate adhesive for transdermal patch. J. Control. Release. 2023; 353:475–489.
32. Yang D., Liu C., Piao H., Quan P., Fang L. Enhanced Drug Loading in the Drug-in-Adhesive Transdermal Patch Utilizing a Drug-Ionic Liquid Strategy: Insight into the Role of Ionic Hydrogen Bonding. Mol. Pharm. 2021;18: 1157–1166.
33. Yang D., Liu C., Quan P., Fang L. Molecular mechanism of high capacity-high release transdermal drug delivery patch with carboxyl acrylate polymer: Roles of ion-ion repulsion and hydrogen bond. Int. J. Pharm. 2020.
34. Choi I.J., Cha H.R., Hwang S.J., Baek S.K., Lee J.M., Choi S.O. Live Vaccinia Virus-Coated Microneedle Array Patches for Smallpox Vaccination and Stockpiling. Pharmaceutics. 2021; 13:209.
35. Sullivan S.P, Koutsonanos D.G., Del Pilar Martin M., Lee J.W., Zarnitsyn V., Choi S.O., Murthy N., Compans R.W., Skountzou I., Prausnitz M.R. Dissolving polymer microneedle patches for influenza vaccination. Nat. Med. 2010; 16: 915–920.
36. Singh P., Muhammad I., Nelson N.E., Tran K.T.M., Vinikoor T., Chorsi M.T., D’Orio E., Nguyen T.D. Transdermal delivery for gene therapy. Drug Deliv. Transl. Res. 2022; 12:2613–2633.
37. Xu Q., Li X., Zhang P., Wang Y. Rapidly dissolving microneedle patch for synergistic gene and photothermal therapy of subcutaneous tumor. J. Mater. Chem. B. 2020;8: 4331–4339.
38. Islam M.R., Uddin S., Chowdhury M.R., Wakabayashi R., Moniruzzaman M., Goto M. Insulin Transdermal Delivery System for Diabetes Treatment Using a Biocompatible Ionic Liquid-Based Microemulsion. ACS Appl. Mater. Interfaces. 2021; 13: 42461–42472.
39. Jorge L.R., Harada L.K., Silva E.C., Campos W.F., Moreli F.C., Shimamoto G., Pereira J.F.B., Oliveira J.M., Jr., Tubino M., Vila M., et al. Non-invasive Transdermal Delivery of Human Insulin Using Ionic Liquids: In vitro Studies. Front. Pharmacol. 2020; 11:243
40. Lin X., Choi D., Hong J. Insulin particles as building blocks for controlled insulin release multilayer nano-films. Mater. Sci. Eng. C Mater. Biol. Appl. 2015; 54:239–244.
41. Maciel V.B.V., Yoshida C.M.P., Pereira S., Goycoolea F.M., Franco T.T. Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery. Molecules. 2017; 22:1707.
42. Tanner E.E.L., Ibsen K.N., Mitragotri S. Transdermal insulin delivery using choline-based ionic liquids (CAGE) J. Control. Release. 2018; 286:137–144.
43. Sugumar V., Ang K.P., Alshanon A.F., Sethi G., Yong P.V.C., Looi C.Y., Wong W.F. A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method. Pharmaceutics. 2022; 14:1406.
44. Seong K.Y., Seo M.S., Hwang D.Y., O’Cearbhaill E.D., Sreenan S., Karp J.M., Yang S.Y. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin. J. Control. Release. 2017; 265:48–56.
45. Ogawa R., Stachnik J.M., Echizen H. Clinical pharmacokinetics of drugs in patients with heart failure: An update (part 1, drugs administered intravenously) Clin. Pharmacokinet. 2013; 52:169–185.
46. Lainscak M., Vitale C., Seferovic P., Spoletini I., Cvan Trobec K., Rosano G.M. Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure. Int. J. Cardiol. 2016; 224:191–198.
47. Mangoni A.A., Jarmuzewska E.A. The influence of heart failure on the pharmacokinetics of cardiovascular and non-cardiovascular drugs: A critical appraisal of the evidence. Br. J. Clin. Pharmacol. 2019;85:20–36.
48. Ahad A., Aqil M., Kohli K., Sultana Y., Mujeeb M., Ali A. Interactions between novel terpenes and main components of rat and human skin: Mechanistic view for transdermal delivery of propranolol hydrochloride. Curr. Drug Deliv. 2011; 8: 213–224.
49. Corbo M., Liu J.C., Chien Y.W. Bioavailability of propranolol following oral and transdermal administration in rabbits. J. Pharm. Sci. 1990; 79:584–587.
50. Matsuoka H., Kuwajima I., Shimada K., Mitamura H., Saruta T. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: Randomized, double-blind, placebo-controlled study. J. Clin. Hypertens. 2013;15: 806–814
51. Hara T., Yagi S., Akaike M., Sata M. Transdermal patch of bisoprolol for the treatment of hypertension complicated with aortic dissection. Int. J. Cardiol. 2015; 198: 220–221.
52. Shinohara M., Fujino T., Koike H., Kitahara K., Kinoshita T., Yuzawa H., Suzuki T., Fukunaga S., Kobayashi K., Aoki J., et al. Assessment of a novel transdermal selective beta1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease. J. Cardiol. 2017; 70:212–219
53. Kiuchi S, Hisatake S, Kabuki T, Oka T, Dobashi S., Fujii T., Sano T., Ikeda T. Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension. Clin. Exp. Hypertens. 2020; 42:539–544.
54. Yasui T, Oka T, Shioyama W, Oboshi M, Fujita M. Bisoprolol transdermal patch treatment for patients with atrial fibrillation after noncardiac surgery: A single-center retrospective study of 61 patients. SAGE Open Med. 2020; 8: 7817.
55. Takahashi Y, Sonoo T, Nakano H., Naraba H., Hashimoto H., Nakamura K. The influence of edema on the bisoprolol blood concentration after bisoprolol dermal patch application: A case-control study. Medicine. 2021.
56. Ch. Nagadev, M. Durga Srinivasa Rao, P. Venkatesh, D. Hepcykalarani, R. Prema. A Review on Transdermal Drug Delivery Systems. Asian J. Res. Pharm. Sci. 2020; 10(2):109-114.
57. Saudagar RB, Samuel S. Ethosomes: Novel noninvasive carrier for Transdermal Drug Delivery. Asian J. Pharm. Tech. 2016; 6(2): 135-38.
58. Roge Ashish B, Sakhare Ram S, Bakal RL, Channawar MA, Bakde BV, Gawande SR, Chandewar AV. Ethosomes: Novel Approach in Transdermal Drug Delivery System. Research J. Pharma. Dosage Forms and Tech. 2010; 2(1): 23-27.